Archives

by in
Entry Author Date Location
Zillions of Biotech Conferences Want You. Which Should You Attend? 05/20/13 National
East Coast Life Sciences Roundup: Termeer, Atlas, OSI Pharma & More 05/17/13 Boston
Atlas Leans on Amgen, Novartis to Build New Startups 05/16/13 Boston
Ensysce’s Bet: Combining Two Risky Drug Technologies That Add Up 05/09/13 Texas
San Diego Life Sciences Roundup: Topera, Afraxis, Trovagene, & More 05/03/13 San Diego
Abide Therapeutics and Merck Unveil Diabetes Drug Collaboration 05/02/13 San Diego
A Biotech Innovation Supply Chain: Reality or Fantasy? 04/22/13 National
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
Ra Pharmaceuticals Clinches Merck Deal for Up to $200 Million 04/01/13 Boston
Pfizer Yields to Rivals in Hep C Drug Race 03/13/13 New York
East Coast Life Sciences Roundup: Merck, Celgene, PTC, Cerulean 03/08/13 Boston
Roger Perlmutter Returns to Merck, Looks to Biotech Future (Again) 03/07/13 New York
With Fluorine Tech, SciFluor Aims to Vindicate “Me-Too” Drugs 02/25/13 Boston
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
East Coast Life Sciences Roundup: Jounce, Tokai, Lux, & More 02/15/13 National
Lycera Enters Into Second Collaboration Deal with Merck 02/12/13 Detroit
Alder Biopharma Looks to Take On Migraines, and the World 01/24/13 Seattle
Brook Byers of Kleiner Perkins on Sticking With Healthcare 01/16/13 San Francisco
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
The Wisconsin Biotech Story: Slow and Steady Wins the Race 12/10/12 National
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
East Coast Life Sciences Roundup: Bristol-Myers, Alnylam, Merck, & More 11/16/12 Boston
Hepatitis C Treatments from Gilead, Abbott Wow Liver Meeting 11/13/12 Boston
Exclusive: Skyline Ventures Cuts Partners, Postpones Fundraising 10/26/12 National
San Diego Life Sciences Roundup: Accelrys, AirStrip, Ligand, & More 10/25/12 San Diego
Rapid7, Veracode, Boston Scientific, Vaxxas in the Boston Deals Roundup 10/10/12 Boston
Watch Out SF, Boston Is Turning Into Biotech’s No. 1 Cluster 10/08/12 National
Zymeworks Hits Antibody Drug Milestone For Merck, Raises $11M 09/06/12 Seattle
Would Longer Drug Patents Really Lead to Lower Drug Prices? 09/05/12 Seattle
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Page 1 of 13 next page »